Related Experiment Video
Updated: Nov 25, 2025

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
Antipsychotics and hemodialysis: A systematic review
Roshan Sutar1, Mahendra Kumar Atlani2, Pooja Chaudhary1
1Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), Bhopal, India.
This review examines antipsychotic use in hemodialysis patients, finding modest evidence for specific oral and long-acting formulations. Careful consideration of drug properties and dialysis parameters is crucial for safe and effective management of behavioral symptoms.
Area of Science:
- Pharmacology
- Nephrology
- Psychiatry
Background:
- Antipsychotics manage behavioral issues in hemodialysis patients.
- Limited data exists on antipsychotic pharmacokinetics during hemodialysis.
- Current guidelines offer minimal specific advice beyond avoiding certain drugs or dosage increases in renal failure.
Purpose of the Study:
- To systematically review the safety and efficacy of antipsychotics in patients undergoing hemodialysis.
- To analyze available literature on antipsychotic pharmacokinetics in this specific patient population.
Main Methods:
- Systematic analysis of online data from 1981 to 2019.
- Inclusion criteria focused on studies reporting safety and efficacy outcomes (adverse effects, symptom relapse) of antipsychotics in hemodialysis patients.
- Outcome assessment involved reviewing 14 case reports and 1 case series.
Main Results:
- Several oral antipsychotics (aripiprazole, ziprasidone, olanzapine, risperidone) and long-acting formulations (risperidone, paliperidone) were studied.
- Blood levels of antipsychotics were unaffected in some studies, while others suggested dose timing relative to dialysis sessions.
- Schizophrenia exacerbation was the most common psychiatric issue reported in patients undergoing hemodialysis.
Conclusions:
- Modest evidence supports multiple dosing regimens for oral aripiprazole, ziprasidone, olanzapine, and risperidone.
- Long-acting risperidone and paliperidone are well-tolerated; a reduced paliperidone dose may suffice.
- Antipsychotic selection requires considering protein binding, dialysis clearance, dialysis duration, administration route, and bowel absorption in hemodialysis patients.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Psychosis and Antipsychotic Drugs: Overview
Hemodialysis III: Nursing Management
Hemodialysis II: Procedure and Complications
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...

